ESR1 and cancer: Isoflavones are structurally and functionally similar to estrogen, and depending on the concentration of estrogen at each site, isoflavones can bind to become estrogen receptor agonists or antagonists, preventing cancer through estrogen-dependent mechanisms in the estrogen signaling pathway [9,91].